Amifostine in the management of radiation-induced and chemo-induced mucositis

Simple item page
dc.contributor.authorBensadoun, R.
dc.contributor.authorSchubert, M.
dc.contributor.authorLalla, R.
dc.contributor.authorKeefe, D.
dc.date.issued2006
dc.descriptionThe original publication can be found at www.springerlink.com
dc.description.abstractIntroduction Mucositis is a significant complication of cancer therapy, with important clinical and economic implications. In June 2005, the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO) conducted an evidence-based update review of the literature on mucositis. The goal of this literature review is to update previously published guidelines for the management of mucositis. Results This article reports the findings of the subgroup charged with reviewing the literature related to amifostine.
dc.description.statementofresponsibilityRene-Jean Bensadoun, Mark M. Schubert, Rajesh V. Lalla and Dorothy Keefe
dc.identifier.citationSupportive Care in Cancer, 2006; 14(6):566-572
dc.identifier.doi10.1007/s00520-006-0047-4
dc.identifier.issn0941-4355
dc.identifier.issn1433-7339
dc.identifier.orcidKeefe, D. [0000-0001-9377-431X]
dc.identifier.urihttp://hdl.handle.net/2440/23012
dc.language.isoen
dc.publisherSpringer-Verlag
dc.source.urihttp://www.springerlink.com/content/5857l17202n61457/
dc.subjectamifostine
dc.subjectmucositis
dc.subjectradiotheraphy
dc.subjectchemotheraphy
dc.titleAmifostine in the management of radiation-induced and chemo-induced mucositis
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications